Mayne wins breathing room in fight to get Cosette merger over the line
M&A 2025-11-13 11:11 pm By Cat Fredenburgh
Please login to bookmark Close

Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au